|
Junior Member
|
https://www.straitstimes.com/asia/s...eing-phased-out
引用:
Published
Jul 16, 2021, 9:44 pm SGT
KUALA LUMPUR - Malaysia has denied that a move to phase out the administering of the Chinese-made Sinovac vaccine is due to efficacy issues, saying it will order more in the future in the event of shortages.
The delivery of the current order for 12 million Sinovac doses, covering nearly a fifth of the population, will be completed by the end of this month, coordinating minister for immunisation Khairy Jamaluddin, said on Friday (July 16).
The government is purchasing an additional three million doses, which will be delivered by end-July or early-August, he said, adding that Sinovac would still be available for those at risk of anaphylaxis as well as through private vaccinations.
"It has nothing to do with Sinovac's efficacy. There has been a lot of speculation on this. It is because we will be receiving our entire delivery by the end of July and August," Mr Khairy told a news conference.
The order of 12 million doses will be fully distributed by July 21, earlier than scheduled, because the government had asked for it to be brought forward to speed up vaccinations, he said.
The announcement to stop using Sinovac's vaccine, which is formulated from an inactivated virus, comes amid concern over its efficacy against new and more contagious variants of the coronavirus.
|
DeepL
引用:
吉隆坡--馬來西亞否認逐步停止使用中國製造的西諾瓦克疫苗的舉措是由於療效問題，並表示在未來出現短缺時將訂購更多疫苗。
免疫協調部長Khairy Jamaluddin週五（7月16日）說，目前訂購的1200萬劑西諾瓦克疫苗將在本月底前完成交付，覆蓋近五分之一的人口。
他說，政府正在購買額外的300萬劑疫苗，這些疫苗將在7月底或8月初交付，他補充說，Sinovac仍將提供給那些有過敏性休克風險的人，以及通過私人疫苗接種。
"這與Sinovac的療效無關。關於這一點，已經有很多猜測。這是因為我們將在7月底和8月收到全部貨物，"凱里先生在一次新聞發佈會上說。他說，1200萬劑的訂單將在7月21日之前全部分發完畢，比預定時間早，因為政府要求提前分發，以加快疫苗接種。
宣佈停止使用由滅活病毒配製的華銳疫苗，是因為人們擔心它對冠狀病毒的新的和更具傳染性的變種的效力。
|
|